Eptifibatide
Product Images NDC 62147-0602

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 62147-0602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Usv Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Efti (Eftif)

Efti (Eftif)
Chemical structure diagram of Eptifibatide, showing its molecular connectivity including peptide bonds, sulfur disulfide bridge, and various functional groups such as carboxyl, amide, guanidine, and indole moieties. The structure illustrates the cyclic peptide nature of Eptifibatide.*
FDA Label Image

Efti-vial-label-0.75 mg (Epfti 0.75mg)

Efti-vial-label-0.75 mg (Epfti 0.75mg)
Label for Eptifibatide Injection 75 mg per 100 mL (0.75 mg per mL) by USV Private Limited. The label specifies that the product is for intravenous use only, Rx only, and is supplied in a 100 mL single-use vial. It includes storage instructions, dosage guidance to see insert, and manufacturing details from Mumbai, India.*
FDA Label Image

Efti-vial-label-2-mg (Epfti 2mg)

Efti-vial-label-2-mg (Epfti 2mg)
Label for Eptifibatide Injection 200 mg per 100 mL (2 mg per mL) in a 100 mL single-use vial, indicated for intravenous use only. It lists storage instructions, pH, and ingredient details. The label shows it is manufactured for USV Private Limited, Mumbai, India, with a barcode and NDC number 62147-0602-1.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph comparing the percentage of patients with events over 30 days for two treatments: Eptifibatide Injection and Placebo. The x-axis represents time in days, and the y-axis shows the percentage of patients with events. The graph features a solid line for Eptifibatide Injection and a dashed line for Placebo, illustrating cumulative event rates over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.